HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

phosphono-platelet activating factor

structure given in first source
Also Known As:
1-O-hexadecyl-2-O-acetylglyceryl-3(2-trimethyl ammoniummethyl)phosphonate; PAF-P; phosphono-PAF; platelet activating factor-phosphonate; Ethanaminium, 2-((2-(acetyloxy)-3-(hexadecyloxy)propoxy)hydroxyphosphinyl)-N,N,N-trimethyl-, hydroxide, inner salt
Networked: 10 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Pajitnev, Dimitri: 1 article (01/2013)
2. Berkowitsch, Alexander: 1 article (01/2013)
3. Pitschner, Heinz F: 1 article (01/2013)
4. Greiss, Harald: 1 article (01/2013)
5. Lehinant, Stefan: 1 article (01/2013)
6. Hamm, Christian W: 1 article (01/2013)
7. Schmitt, Jörn: 1 article (01/2013)
8. Erkapic, Damir: 1 article (01/2013)
9. Rixe, Johannes: 1 article (01/2013)
10. Zaltsberg, Sergey: 1 article (01/2013)

Related Diseases

1. Atrial Fibrillation
2. Chronic Obstructive Pulmonary Disease (COPD)
3. Hypertension (High Blood Pressure)
4. Atrial Premature Complexes (Premature Atrial Contraction)
5. Ventricular Premature Complexes (Premature Ventricular Contraction)

Related Drugs and Biologics

1. Methacholine Chloride (Methacholine)
2. Polyvinyl Chloride (PVC)
3. Phenylephrine (Neo-Synephrine)
4. Amiodarone (Amiodarona)
5. SR-AT

Related Therapies and Procedures

1. Continuous Positive Airway Pressure
2. Parasympathectomy
3. Sympathectomy (Sympathectomies)